ym 58483 has been researched along with Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funatsu, M; Ishikawa, J; Kubota, H; Miyazaki, Y; Ohta, M; Okamoto, Y; Takeuchi, M; Yonetoku, Y; Yoshimura-Ishikawa, N; Yoshino, T | 1 |
| Alzina, S; De Alba, J; Esteve, C; González, J; Gual, S; Horrillo, R; Jover, I; Miralpeix, M; Sentellas, S; Tarrasón, G; Vidal, B; Vidal, L | 1 |
2 other study(ies) available for ym 58483 and Hypersensitivity
| Article | Year |
|---|---|
Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: synthesis and CRAC channel inhibitory activity of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilides.
Topics: Anilides; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Enzyme Inhibitors; Female; Humans; Hypersensitivity; Interleukin-2; Jurkat Cells; Lymphocyte Activation; Male; Mice; Pulmonary Eosinophilia; Pyrazoles; Rats; Rats, Inbred BN; Structure-Activity Relationship; T-Lymphocytes; Thapsigargin | 2008 |
Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma.
Topics: Animals; Asthma; Aza Compounds; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Drug Evaluation, Preclinical; Half-Life; Humans; Hypersensitivity; Indoles; Interleukin-2; Jurkat Cells; Microsomes; Models, Biological; Ovalbumin; Protein Binding; Pyridines; Pyrroles; Rats; Structure-Activity Relationship | 2015 |